Related Experiment Video
Updated: Jul 7, 2026

12:23
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study
M Nakamura1, I Miyazawa, K Fujihara
1Dept. of Neurology, Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Japan. mnakamura@em.neurol.med.tohoku.ac.jp
Journal of Neurology
|January 31, 2008
Summary
Neuromyelitis optica (NMO) spinal cord lesions predominantly affect the central gray matter, unlike multiple sclerosis (MS) lesions which favor white matter. MRI reveals distinct lesion patterns differentiating these conditions.
Area of Science:
- Neuroimaging
- Neurology
- Radiology
Background:
- Distinguishing neuromyelitis optica (NMO) from multiple sclerosis (MS) is crucial for appropriate treatment.
- Magnetic Resonance Imaging (MRI) is key in evaluating spinal cord lesions in demyelinating diseases.
Observation:
- Spinal cord lesions in NMO predominantly involve the central gray matter in both acute and chronic stages.
- Lesion density analysis shows higher concentrations in the central gray matter in NMO.
- In contrast, multiple sclerosis lesions are primarily located in the lateral and posterior white matter.
Findings:
- Neuromyelitis optica (NMO) exhibits characteristic spinal cord MRI lesions centered in the gray matter.
- Multiple sclerosis (MS) shows lesions predominantly in the white matter regions.
- T1-hypointense lesions were observed in the central region in NMO, but not in MS.
Implications:
- MRI findings of central gray matter involvement strongly suggest NMO over MS.
- This differentiation aids in accurate diagnosis and management of patients with suspected demyelinating spinal cord disorders.
- Further research into the specific pathological correlates of these MRI patterns is warranted.
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
